And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to chaperone our shortest person for more lessons in the vintage driving machine, check in on the Pharmalot ancestors, and catch up on some reading and napping. And what about you? This is a good time to make time for someone special or plan a spring break. Or you could place bets on the likelihood that a wall gets built on a certain border. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The day after Egalet bought Zorvolex, an anti-inflammatory pain reliever, the company boosted the price by nearly 70 percent, which represents the largest single brand price hike in over a year, Axios writes, citing 46Brooklyn, a nonprofit research firm that tracks pricing. As of Feb. 1, a 90-pill bottle now has a price tag of $650, compared with $383 a year ago, according to Elsevier’s Gold Standard Drug Database. The previous owner, Iroko Pharmaceutical, already raised the price by 9.4 percent on Jan. 9, making this the only drug to experience more than one increase this year.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy